Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial
P. Cram, F. D. Wolinsky, Y. Lou, S. W. Edmonds, S. F. Hall, D. W. Roblin, N. C. Wright, M. P. Jones, K. G. Saag, behalf of the PAADRN Investigators on behalf of the PAADRN Investigators
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'Patient-activation and guideline-concordant pharmacological treatment after bone density testing: the PAADRN randomized controlled trial'. Together they form a unique fingerprint.